BioNexus Gene Lab Corp.
BGLC
$5.38
-$0.04-0.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.50% | -38.35% | -26.17% | -32.69% | 207.84% |
| Total Receivables | 50.80% | 77.44% | 69.89% | 49.08% | -39.37% |
| Inventory | 17.68% | 9.48% | 22.04% | 25.38% | -11.39% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -18.66% | -17.24% | -7.66% | -14.88% | 50.05% |
|
|
|||||
| Total Current Assets | -18.66% | -17.24% | -7.66% | -14.88% | 50.05% |
| Net Property, Plant & Equipment | 12.83% | 7.78% | 5.14% | 19.27% | 10.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -15.43% | -15.07% | -8.47% | -4.10% | 41.03% |
|
|
|||||
| Total Accounts Payable | 43.22% | -17.25% | 7.21% | -34.20% | -47.61% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -92.67% | -59.35% | 30.30% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.89% | 60.62% | 46.82% | 42.18% | 230.43% |
| Total Finance Division Other Current Liabilities | 81.29% | 44.01% | 110.06% | 683.58% | 363.85% |
| Total Other Current Liabilities | 81.29% | 44.01% | 110.06% | 683.58% | 363.85% |
| Total Current Liabilities | 25.61% | -9.09% | 19.65% | -13.94% | -25.42% |
|
|
|||||
| Total Current Liabilities | 25.61% | -9.09% | 19.65% | -13.94% | -25.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -92.67% | -59.35% | 30.30% | -- | -- |
| Capital Leases | -22.66% | 66.55% | 61.64% | 70.07% | 515.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -52.94% | -58.97% |
| Total Liabilities | 19.15% | -6.00% | 21.19% | -9.61% | -17.63% |
|
|
|||||
| Common Stock & APIC | 0.82% | 0.82% | 0.82% | 0.30% | 57.29% |
| Retained Earnings | -167.72% | -108.72% | -86.66% | -73.73% | -311.19% |
| Treasury Stock & Other | 13.04% | 6.86% | 2.15% | 16.56% | -1.77% |
| Total Common Equity | -21.20% | -16.83% | -13.82% | -3.09% | 60.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.20% | -16.83% | -13.82% | -3.09% | 60.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.20% | -16.83% | -13.82% | -3.09% | 60.06% |
|
|
|||||